Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LFCR

Lifecore Biomedical Inc

May 22 • 04:00PM ET

4.93

-0.05 -1.00 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Micro • NASD

Peers: ANIK OCUL AMPH XERS KPTI

| Held by: VTI IWM VXF IWO VTWO IWC IWN VTWG RSSL VTWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.30	Insider Own	8.19%	Shs Outstand	37.48M	Perf Week	12.05%
Market Cap	184.92M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	34.44M	Perf Month	0.20%
Enterprise Value	363.48M	PEG	-	EPS next Q	-	Inst Own	71.88%	Short Float	7.84%	Perf Quarter	-32.37%
Income	-44.36M	P/S	1.43	EPS this Y	-	Inst Trans	1.34%	Short Ratio	8.15	Perf Half Y	-34.18%
Sales	128.87M	P/B	-	EPS next Y	-	ROA	-15.09%	Short Interest	2.70M	Perf YTD	-39.73%
Book/sh	-0.76	P/C	8.89	EPS next 5Y	-	ROE	-76.41%	52W High	8.98 -45.10%	Perf Year	-26.09%
Cash/sh	0.55	P/FCF	-	EPS past 3/5Y	31.55% 0.55%	ROIC	-22.83%	52W Low	3.62 36.00%	Perf 3Y	-8.02%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.02% -26.24%	Gross Margin	31.27%	Volatility	8.28% 6.18%	Perf 5Y	-59.66%
Dividend TTM	-	EV/Sales	2.82	EPS Y/Y TTM	-430.88%	Oper. Margin	-9.35%	ATR (14)	0.31	Perf 10Y	-57.24%
Dividend Ex-Date	-	Quick Ratio	2.41	Sales Y/Y TTM	0.47%	Profit Margin	-34.42%	RSI (14)	53.66	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	3.79	EPS Q/Q	9.42%	SMA20	2.68%	Beta	1.08	Target Price	6.67
Payout	-	Debt/Eq	7.23	Sales Q/Q	-34.02%	SMA50	6.15%	Rel Volume	0.47	Prev Close	4.98
Employees	406	LT Debt/Eq	7.16	Earnings	May 06 BMO	SMA200	-27.33%	Avg Volume	331.45K	Price	4.93
IPO	Feb 15, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.44% 18.47%	Trades		Volume	154,273	Change	-1.00%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-17-26	Upgrade	Barrington Research	Mkt Perform → Outperform	$5.50
Sep-04-25	Initiated	KeyBanc Capital Markets	Sector Weight
May-21-25	Initiated	William Blair	Outperform
Sep-05-24	Initiated	Craig Hallum	Buy	$8
Aug-28-24	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-20-23	Downgrade	Stephens	Overweight → Equal-Weight	$11 → $2

May-21-26 07:05AM	Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference (GlobeNewswire) +8.97%
May-12-26 04:05PM	Lifecore Biomedical to Participate at CDMO Live Europe (GlobeNewswire)
May-06-26 07:20AM	Lifecore Biomedical: Q1 Earnings Snapshot (Associated Press)
07:05AM	Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update (GlobeNewswire)
Apr-29-26 04:05PM	Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026 (GlobeNewswire)
04:05PM	Loading…
Apr-22-26 04:05PM	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.93%
Apr-08-26 08:00AM	Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit (GlobeNewswire)
Mar-26-26 04:05PM	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.64% -5.43%
07:00AM	Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer (GlobeNewswire)
Mar-23-26 07:00AM	Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company (GlobeNewswire)
Mar-16-26 03:01PM	Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) -33.26%
08:00AM	Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update (GlobeNewswire)
Mar-10-26 04:05PM	Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum (GlobeNewswire)
Mar-09-26 04:05PM	Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026 (GlobeNewswire)
Mar-04-26 04:03PM	Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment (GlobeNewswire)
07:05AM	Loading…
Feb-17-26 07:05AM	Lifecore Biomedical to Participate at DCAT Week 2026 (GlobeNewswire)
Jan-29-26 05:09PM	HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Jan-16-26 04:45PM	Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:25AM	What Contributes to Lifecore Biomedical's (LFCR) Distinct Competitive Advantage? (Insider Monkey)
Jan-15-26 10:39AM	Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Dec-24-25 12:30PM	HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Dec-18-25 07:00AM	Lifecore Biomedical to be Added to Nasdaq Biotech Index (GlobeNewswire)
Dec-17-25 07:00AM	Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer (GlobeNewswire) +9.86%
Dec-16-25 07:00AM	Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-07-25 02:49PM	Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Nov-11-25 04:05PM	Lifecore Biomedical to Participate in Upcoming Investor Conferences (GlobeNewswire) +6.17% +6.20%
Nov-10-25 08:41AM	An Analysis of LifeCore's (LFCR) Growth Potential (Insider Monkey) +6.42%
Nov-07-25 12:00AM	Lifecore Biomedical Inc (LFCR) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com)
Nov-06-25 05:40PM	Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates (Zacks)
04:38PM	Lifecore Biomedical: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update (GlobeNewswire)
Nov-04-25 08:40AM	Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Miss Estimates (Zacks)
Oct-30-25 04:05PM	Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025 (GlobeNewswire)
08:13AM	Here's Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3 (Insider Monkey)
Oct-29-25 07:00AM	Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company (GlobeNewswire)
06:07AM	Lifecore and PolyPeptide link for US peptide manufacturing (Pharmaceutical Technology)
Oct-28-25 07:00AM	Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market (GlobeNewswire)
Oct-13-25 07:00AM	Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events (GlobeNewswire)
Sep-26-25 10:00AM	Lifecore Biomedical (LFCR) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
Sep-23-25 04:30PM	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -10.70%
Sep-12-25 09:09AM	Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock? (Zacks)
Sep-04-25 04:05PM	Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference (GlobeNewswire) -5.16%
Sep-02-25 04:05PM	Lifecore Biomedical to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-19-25 09:36AM	Does LifeCore (LFCR) Have a High Expected Value? (Insider Monkey)
Aug-07-25 07:35PM	Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -6.70%
06:35PM	Lifecore Biomedical: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-05-25 08:20AM	ImmunityBio (IBRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-31-25 04:05PM	Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jul-24-25 07:40AM	Laughing Water Capital's View on Lifecore Biomedical Inc. (LFCR) (Insider Monkey)
Jul-17-25 04:05PM	Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-17-25 07:00AM	Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer (GlobeNewswire)
Jun-12-25 07:00AM	Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale (GlobeNewswire)
May-27-25 07:00AM	Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer (GlobeNewswire)
Apr-24-25 11:30AM	Laughing Water Capital Top 5 Investments (Q1 2025) (Seeking Alpha)
09:30AM	Laughing Water Capital Q1 2025 Letter (Seeking Alpha)
Apr-22-25 07:00AM	Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference (GlobeNewswire)
Apr-16-25 04:05PM	Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-14-25 07:00AM	Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer (GlobeNewswire) +6.01%
Apr-05-25 12:10PM	China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz (TipRanks)
Apr-04-25 07:09AM	Q3 2025 Lifecore Biomedical Inc Earnings Call (Thomson Reuters StreetEvents) -22.32%
03:01AM	Lifecore Biomedical Inc (LFCR) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Apr-03-25 07:43PM	Lifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call Transcript (Seeking Alpha) -5.42%
05:20PM	Lifecore Biomedical (LFCR) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:17PM	Lifecore Biomedical: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-31-25 05:15PM	Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-27-25 04:05PM	Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025 (GlobeNewswire)
Mar-17-25 07:00AM	Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome (GlobeNewswire)
Mar-07-25 09:55AM	Is Lifecore Biomedical, Inc. (LFCR) the Best Micro Cap Stock to Buy Now? (Insider Monkey)
07:20AM	Greenhaven Road Capitals Updates on Lifecore Biomedical (LFCR) (Insider Monkey)
Feb-26-25 04:05PM	Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences (GlobeNewswire)
Feb-03-25 07:00AM	Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference (GlobeNewswire)
Jan-22-25 09:36AM	Here are Laughing Water Capitals Updates on Lifecore Biomedical (LFCR) (Insider Monkey)
Jan-17-25 05:24PM	Lifecore Biomedical Announces Special Stockholder Meeting (GlobeNewswire)
Jan-07-25 09:00AM	Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million (GlobeNewswire) -13.97%
Jan-06-25 04:05PM	Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -9.84%
Jan-03-25 09:44AM	Q2 2025 Lifecore Biomedical Inc Earnings Call (Thomson Reuters StreetEvents) +14.41%
02:00AM	Lifecore Biomedical Inc (LFCR) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Rising ... (GuruFocus.com)
Jan-02-25 05:15PM	Lifecore Biomedical (LFCR) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -10.36%
04:15PM	Lifecore Biomedical: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Jan-01-25 07:01AM	Earnings To Watch: Lifecore Biomedical Inc (LFCR) Reports Q2 2025 Result (GuruFocus.com)
Dec-29-24 05:00AM	What to Expect in the Markets This Week (Investopedia)
Dec-19-24 04:05PM	Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025 (GlobeNewswire)
07:00AM	Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment (GlobeNewswire)
Dec-12-24 10:03AM	Heres Why Arquitos Capital Management Largely Exited Lifecore (LFCR) (Insider Monkey)
Nov-26-24 04:05PM	Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO (GlobeNewswire)
Nov-21-24 04:17PM	Lifecore Biomedical Hosts Virtual Investor Day (GlobeNewswire) -6.68%
Nov-15-24 08:44AM	Heres Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR) (Insider Monkey)
Nov-12-24 04:05PM	Lifecore Biomedical to Present at Stephens Annual Investment Conference (GlobeNewswire) +7.34%
Nov-07-24 07:00AM	Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024 (GlobeNewswire)
Nov-04-24 07:00AM	Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations (GlobeNewswire)
Oct-17-24 07:30AM	Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer (GlobeNewswire) +9.76%
Oct-07-24 09:12PM	Legion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical Inc (GuruFocus.com) -5.39% -5.50%
01:00AM	Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
Oct-04-24 07:52AM	Lifecore Biomedical: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +14.35%
07:30AM	Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
07:20AM	Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock (GlobeNewswire)
Oct-03-24 04:05PM	Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024 (GlobeNewswire) -5.33%

Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.

PresidentMr. Paul Josephs

Executive VP & CFOMr. Ryan D. Lake CPA

Chief Legal & Administration Officer and Corporate SecretaryMr. Thomas D. Salus

Senior Vice President of OperationsMr. Thomas Guldager

Director of Internal Audit & Chief Compliance OfficerMr. Aaron Perlitsh

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
English Aron R.	10% Owner	May 27 '25	Sale	6.50	1,139,504	7,411,562	414,599	May 28 08:06 PM
English Aron R.	10% Owner	May 28 '25	Sale	7.12	150,419	1,071,555	264,180	May 28 08:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LFCR

Lifecore Biomedical Inc

Upgrade your Finviz experience